These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27196067)

  • 1. Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples.
    Rice NT; Szlam F; Varner JD; Bernstein PS; Szlam AD; Tanaka KA
    PLoS One; 2016; 11(5):e0154127. PubMed ID: 27196067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
    Tanaka KA; Szlam F; Rusconi CP; Levy JH
    Thromb Haemost; 2009 May; 101(5):827-33. PubMed ID: 19404534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin.
    Szlam F; Luan D; Bolliger D; Szlam AD; Levy JH; Varner JD; Tanaka KA
    Thromb Res; 2010 May; 125(5):432-7. PubMed ID: 20004955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.
    Gissel M; Orfeo T; Foley JH; Butenas S
    Thromb Res; 2012 Dec; 130(6):948-55. PubMed ID: 22951415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing Plasma Composition Data to Help Determine Procoagulant Dynamics in Patients with Thermal Injury: A Computational Assessment.
    Bravo MC; Tejiram S; McLawhorn MM; Moffatt LT; Orfeo T; Jett-Tilton M; Pusateri AE; Shupp JW; Brummel-Ziedins KE
    Mil Med; 2019 Mar; 184(Suppl 1):392-399. PubMed ID: 30901410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin.
    Furugohri T; Morishima Y
    Thromb Res; 2015 Sep; 136(3):658-62. PubMed ID: 26188924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation.
    Parunov LA; Fadeeva OA; Balandina AN; Soshitova NP; Kopylov KG; Kumskova MA; Gilbert JC; Schaub RG; McGinness KE; Ataullakhanov FI; Panteleev MA
    J Thromb Haemost; 2011 Sep; 9(9):1825-34. PubMed ID: 21696535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma.
    Gorczyca ME; Nair SC; Jilma B; Priya S; Male C; Reitter S; Knoebl P; Gilbert JC; Schaub RG; Dockal M; McGinness KE; Pabinger I; Srivastava A
    J Thromb Haemost; 2012 Aug; 10(8):1581-90. PubMed ID: 22632032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor.
    Chang JY; Chantrathammachart P; Monroe DM; Key NS
    Thromb Res; 2012 Sep; 130(3):e151-7. PubMed ID: 22658294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma.
    Cardenas JC; Rahbar E; Pommerening MJ; Baer LA; Matijevic N; Cotton BA; Holcomb JB; Wade CE
    J Trauma Acute Care Surg; 2014 Dec; 77(6):839-45. PubMed ID: 25099452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.
    Prior SM; Mann KG; Freeman K; Butenas S
    Anal Biochem; 2018 Jun; 551():19-25. PubMed ID: 29746819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B; Barbay V; Borg JY; Le Cam-Duchez V
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
    Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
    Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher concentrations of heparin and hirudin are required to inhibit thrombin generation in tissue factor-activated cord plasma than in adult plasma.
    Baier K; Cvirn G; Fritsch P; Köstenberger M; Gallistl S; Leschnik B; Muntean W
    Pediatr Res; 2005 May; 57(5 Pt 1):685-9. PubMed ID: 15718352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
    Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
    Haemophilia; 2010 May; 16(3):510-7. PubMed ID: 20050927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation abnormalities in commonly encountered platelet function disorders.
    Sharma T; Brunet JG; Tasneem S; Smith SA; Morrissey JH; Hayward CPM
    Int J Lab Hematol; 2021 Dec; 43(6):1557-1565. PubMed ID: 34185390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates.
    Cvirn G; Gallistl S; Leschnik B; Muntean W
    J Thromb Haemost; 2003 Feb; 1(2):263-8. PubMed ID: 12871499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.